129 related articles for article (PubMed ID: 34557292)
1. Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia.
Ogunleye AJ; Romanova E; Medvedeva YA
F1000Res; 2021; 10():204. PubMed ID: 34557292
[No Abstract] [Full Text] [Related]
2. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
[TBL] [Abstract][Full Text] [Related]
3. Region-Specific Methylation Profiling in Acute Myeloid Leukemia.
Cecotka A; Polanska J
Interdiscip Sci; 2018 Mar; 10(1):33-42. PubMed ID: 29405013
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide computational analysis of potential long noncoding RNA mediated DNA:DNA:RNA triplexes in the human genome.
Jalali S; Singh A; Maiti S; Scaria V
J Transl Med; 2017 Sep; 15(1):186. PubMed ID: 28865451
[TBL] [Abstract][Full Text] [Related]
5. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients.
Gao H; He X; Li Q; Wang Y; Tian Y; Chen X; Wang J; Guo Y; Wang W; Li X
Cancer Med; 2020 Sep; 9(17):6296-6305. PubMed ID: 32628355
[TBL] [Abstract][Full Text] [Related]
9. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
10. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.
Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD
PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation of acute myeloid leukemia and colorectal cancer in a Chinese pedigree with a MLL3 germline mutation.
Yang F; Gong Q; Shi W; Zou Y; Shi J; Wei F; Li Q; Chen J; Li WD
Tumour Biol; 2016 Sep; 37(9):12609-12618. PubMed ID: 27405564
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
13. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
Kroeger H; Jelinek J; Estécio MR; He R; Kondo K; Chung W; Zhang L; Shen L; Kantarjian HM; Bueso-Ramos CE; Issa JP
Blood; 2008 Aug; 112(4):1366-73. PubMed ID: 18523155
[TBL] [Abstract][Full Text] [Related]
14. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
15. Landscape of internal N7-methylguanosine of long non-coding RNA modifications in resistant acute myeloid leukemia.
Han J; Liu Q; Zhou Y; Li D; Wang R
BMC Genomics; 2023 Jul; 24(1):425. PubMed ID: 37501118
[TBL] [Abstract][Full Text] [Related]
16. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
[TBL] [Abstract][Full Text] [Related]
17. A Pilot Study of Aberrant CpG Island Hypermethylation of
Sun J; Zhang J; Wang Y; Li Y; Zhang R
Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
[No Abstract] [Full Text] [Related]
18. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites.
Hogart A; Lichtenberg J; Ajay SS; Anderson S; ; Margulies EH; Bodine DM
Genome Res; 2012 Aug; 22(8):1407-18. PubMed ID: 22684279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
